Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
Date:12/10/2008

7,000

    PEREGRINE PHARMACEUTICALS, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS (continued)

                                                  OCTOBER 31,     APRIL 30,
                                                    2008            2008
                                                  Unaudited

    LIABILITIES AND STOCKHOLDERS' EQUITY

    CURRENT LIABILITIES:
    Accounts payable                              $3,419,000    $2,060,000
    Accrued clinical trial site fees                 550,000       237,000
    Accrued legal and accounting fees                225,000       450,000
    Accrued royalties and license fees               113,000       222,000
    Accrued payroll and related costs                782,000     1,084,000
    Capital lease obligation, current portion         23,000        22,000
    Deferred revenue                               6,472,000     2,196,000
    Deferred government contract revenue           1,701,000             -
    Customer deposits                              1,575,000       838,000
    Other current liabilities                        372,000       331,000

          Total current liabilities               15,232,000     7,440,000

    Capital lease obligation, less current
     portion                                          10,000        22,000
    Commitments and contingencies

    STOCKHOLDERS' EQUITY:
    Preferred stock-$.001 par value;
     authorized 5,000,000 shares; non-voting;
     nil shares outstanding                                -             -
    Common stock-$.001 par value; authorized
     325,000,000 shares; outstanding -
     226,210,617 and 226,210,617,
     respectively                                    226,000       226,000
    Additional paid-in capital                   246,698,000   246,205,000
    Accumulated deficit                         (240,419,000) (230,836,000)

          Total stockholders' equ
'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
2. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
3. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
4. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
5. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
6. Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
7. Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008
8. Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
9. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
10. ISTA Pharmaceuticals to Participate at the RBC Capital Markets Healthcare Conference
11. Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ATLANTA & LAS VEGAS (PRWEB) , ... August 04, 2015 , ... ... released the pitch schedule for vendor participating in The ISE® Lions’ Den and Jungle ... and Spa at Aria in Las Vegas. , During the event, eight emerging security ...
(Date:8/4/2015)... ... 04, 2015 , ... It’s been called “cosmetics heaven,” “mecca for make-up,” and ... Beauty Center in LA. Now MENAJI is part of that experience acting as a ... Center has been a favorite of makeup artists and hair pros as well as ...
(Date:8/4/2015)... ... August 04, 2015 , ... A ... North America IT reseller channel will grow at least 6 percent in 2015, ... 2014 pace and greater than their OEM/vendor partners. , The 2112 Group’s ...
(Date:8/4/2015)... ... 04, 2015 , ... Data2Life , a Tel Aviv-based ... provide pharmaceutical and healthcare organizations with advanced intelligence on drug effects. The product ... filings (including the FDA and HealthCanada), social media and anonymized clinical electronic health ...
(Date:8/4/2015)... NY (PRWEB) , ... August 04, 2015 , ... ... mortgage lender specializing in healthcare finance, announced the closing of a $118 million ... two campus health system located in Smithfield and Clayton, North Carolina. JHSC ...
Breaking Medicine News(10 mins):Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 4Health News:MENAJI Shines in Make-Up Mecca for Stars 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 2Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 3Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 2Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 3
... Legendary blues artists Bobby,Rush and James "Super Chikan" ... Mississippi Blues Marathon and Half-Marathon on Saturday,January 5, 2008. ... located at 200,South Commerce Street, in downtown Jackson. Doors ... go on stage at 8:00 p.m., and the Bobby ...
... recent study by Best,Practices, LLC found that assessment ... team was one of the most important factors ... Product Launch,Through Effective Processes and Authority Roles," can ... their launch governance groups and,maximize the success of ...
... NEW YORK, Dec. 7 Flagship Global Health, Inc.,(OTC ... of its,founders, resigned as a Director and Chairman of ... Flagship,s Chief Executive Officer, stated, "Flagship is,the result of ... unique character he infused into this business will always ...
... study shows that a common antibacterial chemical added to ... in human cells in the laboratoryand does so by ... an increasing number of studies of both lab ... chemicals in household products can cause health problems by ...
... Mental Health,America expresses its deepest sympathies to ... mall shootings. As details surrounding the shootings,continue to ... people across the country -- especially during the ... other community centers.,Mental Health America developed tips to ...
... Picture, Ongoing Medicaid,Funding Crisis Cited, WASHINGTON, Dec. ... (MedPAC) draft recommendation that,skilled nursing facilities (SNFs) should ... Alliance for Quality Nursing Home Care said,MedPAC,s evaluation ... terms of,providing Congress with the overall economic picture ...
Cached Medicine News:Health News:Best Practice Database: Complimentary Excerpt of 'Ensuring a Successful New Product Launch Through Effective Processes and Authority Roles' 2Health News:Flagship Global Health Chairman Resigns 2Health News:Antibacterial chemical disrupts hormone activities 2Health News:In Wake of Omaha Shooting, Mental Health America Provides Tips to Holiday Shoppers to Ease Anxieties 2Health News:MedPAC Again Fails to Evaluate Overall Economic Conditions in Assessing SNF Funding Requirements 2Health News:MedPAC Again Fails to Evaluate Overall Economic Conditions in Assessing SNF Funding Requirements 3
(Date:8/4/2015)... -- Second Quarter 2015 Highlights: , ... of 2014 , Net earnings attributable to Team Health ... adjustments , Diluted net earnings per share of $0.39; ... to $99.4 million 2015 Outlook: , ... 24.0% to 26.0%; Adjusted EBITDA margin remains between 10.5% and ...
(Date:8/4/2015)... Aug. 4, 2015 Among 1,000 U.S. consumers, ... only half of consumers surveyed are aware of prescription ... used use them, according to findings from a new ... service partnership focused on improving the health and well-being ... survey polled 1,000 men and women, ages 21 and ...
(Date:8/4/2015)... Wis. , Aug. 4, 2015  Ironshore ... agreement with Restore Health, a company specializing in ... a double-blind clinical trial, designed to evaluate the ... in development to treat Attention-deficit/hyperactivity disorder (ADHD). This ... Restore Health originally partnered with Ironshore ...
Breaking Medicine Technology:Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 2Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 3Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 4Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 5Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 6Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 7Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 8Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 9Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 10Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 11Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 12Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 13Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 14Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 15Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 16Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 17Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 18Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 19Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 20Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 21Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 22Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 23Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 24Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 25Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 26Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 27Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 28Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 29Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 30Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 31Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 32Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 33New Study Finds Consumers are Leaving Money at the Pharmacy 2New Study Finds Consumers are Leaving Money at the Pharmacy 3Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2
... Nov. 1, 2011 Joseph F. Finn, Jr., C.P.A. ("Finn"), ... ("Epix"), announced today that the back-up compounds and S1P1 lead ... be offered December 8, 2011 in a sealed bid sale. ... total of 640 analogs were synthesized by Epix and/or Amgen ...
... Champions Oncology, Inc.  ("Champions" or  the "Company") (OTC ... engaged in the development of advanced technology solutions and ... drugs, has appointed Gary G. Gemignani to the Company,s ... Officer. Joel Ackerman, the Company,s Chief Executive Officer, served ...
Cached Medicine Technology:Back-Up Compounds and S1P1 Lead Compounds, Assets Generated by Epix Pharmaceuticals, Inc. and Amgen, Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale 2Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation 2Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: